FDA Inspection 833131 — Medtronic Inc

Medtronic Inc — FEI 3004185781

The FDA completed an inspection of Medtronic Inc on May 14, 2013 in Tempe, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 14, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tempe, AZ (United States)

Citations

IDCFRDescription
1243321 CFR 1271.265(f)Return to inventory--procedures